The lower intestinal tract-specific induction of heme oxygenase-1 by glutamine protects against endotoxemic intestinal injury. 2005

Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
Department of Anesthesiology and Resuscitology, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama City 700-8558, Japan.

OBJECTIVE The aim of the present study was to investigate whether glutamine pretreatment improves intestinal injury in rats with endotoxemia by its heme oxygenase-1 induction in the lower intestinal tract. METHODS Randomized, blinded, controlled animal study. METHODS University-based animal research facility. METHODS Sprague-Dawley male rats, weighing 220-250 g (n = 201). METHODS Rats were treated with glutamine (0.75 g/kg) dissolved in lactated Ringer's solution via the tail vein. Endotoxemia was induced in rats by intraperitoneal injection of lipopolysaccharide (10 mg/kg or 20 mg/kg for survival study). Lipopolysaccharide-treated animals were pretreated with glutamine or lactated Ringer's solution 9 hrs before lipopolysaccharide treatment. Some of the glutamine-pretreated animals further received tin mesoporphyrin (1 micromol/kg), a specific inhibitor of heme oxygenase activity, 1 hr before lipopolysaccharide treatment. RESULTS Glutamine treatment markedly induced heme oxygenase-1 messenger RNA and protein in the mucosal epithelial cells as well as in the lamina propria cells in the ileum and the colon, whereas its expression in the duodenum and the jejunum was not influenced by the treatment. Glutamine treatment before lipopolysaccharide administration significantly ameliorated lipopolysaccharide-induced mucosal injury, inflammation, and apoptotic cell death in the ileum and the colon, as judged by significant decreases in tumor necrosis factor-alpha gene expression, histologic damage scores, and expression of activated caspase-3 and by an increase in gene expression of Bcl-2. In addition, glutamine treatment markedly decreased lipopolysaccharide-induced mortality. In contrast, treatment with tin mesoporphyrin abolished the beneficial effect of glutamine pretreatment. CONCLUSIONS Glutamine pretreatment significantly ameliorated intestinal tissue injury of rats following lipopolysaccharide treatment. The same treatment also improved the survival of animals from endotoxemia. The protective effect of glutamine is mediated by its lower intestine-specific induction of heme oxygenase-1, since its inhibition by tin mesoporphyrin completely abolished the beneficial effect of glutamine.

UI MeSH Term Description Entries
D007082 Ileum The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008665 Metalloporphyrins Porphyrins which are combined with a metal ion. The metal is bound equally to all four nitrogen atoms of the pyrrole rings. They possess characteristic absorption spectra which can be utilized for identification or quantitative estimation of porphyrins and porphyrin-bound compounds. Metalloporphyrin
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli

Related Publications

Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
May 2004, The Journal of surgical research,
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
February 2011, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue,
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
January 2009, Shock (Augusta, Ga.),
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
May 2012, Stroke,
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
October 2011, The Journal of toxicological sciences,
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
March 2014, The Journal of surgical research,
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
April 2006, American journal of surgery,
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
August 2007, International journal of surgery (London, England),
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
June 2012, Life sciences,
Kenji Uehara, and Toru Takahashi, and Hiromi Fujii, and Hiroko Shimizu, and Emiko Omori, and Masaki Matsumi, and Masataka Yokoyama, and Kiyoshi Morita, and Reiko Akagi, and Shigeru Sassa
January 2023, Frontiers in medicine,
Copied contents to your clipboard!